Happy Holidays from all of us at ICON. We’re sending every best wish for health, happiness and success in 2026.
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Telemedicine is yet to overcome diversity challenges in dermatology clinical trials
This article explores the benefits and challenges of telemedicine in dermatology clinical trials.
Clinical Trials Arena
-
Leveraging Novel Therapeutics & Diagnostic Assays
A European Biopharmaceutical Review article featuring expert insights from ICON company MolecularMD's Marissa Pearce on Leveraging Novel Therapeutics & Diagnostic Assays, presenting her argument that, although immunotherapy is nothing new, it has much untapped potential yet to be explored.
This article has been taken from EBR - Summer 2019, Pages. 78-84. Samedan Ltd.
